Effects of Hemp-Derived Cannabinoids on Menopause Symptoms (NCT07393672)

🧪 Interventions in This Study

• Hemp-derived cannabinoids (DRUG)
• Placebo (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Washington State University, Dept of Psychology — Pullman, Washington

📞 Contact the Study Coordinator

Phone: (509) 592-0151

Email: carrie.cuttler@wsu.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Menopause

• PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition — Tucson, Arizona
• Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study) — Aurora, Colorado
• Improving Functioning Among Aging Women Veterans — Baltimore, Maryland
• Transdermal Testosterone Gel for Female Sexual Interest and Arousal Disorder in Peri- and Post Menopause — Houston, Texas
• Health, Imaging, and Cognition Across the Menopausal Transition — Sherbrooke, Quebec
• A Study to Investigate the Effect of a Multivitamin, Multi-nutrient Supplement on Mental and Emotional Wellbeing — Chicago, Illinois

Explore by condition: All Menopause clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.